Li Bian

1.9k total citations
118 papers, 1.2k citations indexed

About

Li Bian is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Li Bian has authored 118 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 28 papers in Molecular Biology and 25 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Li Bian's work include HER2/EGFR in Cancer Research (22 papers), Cancer Treatment and Pharmacology (21 papers) and Cancer Cells and Metastasis (12 papers). Li Bian is often cited by papers focused on HER2/EGFR in Cancer Research (22 papers), Cancer Treatment and Pharmacology (21 papers) and Cancer Cells and Metastasis (12 papers). Li Bian collaborates with scholars based in China, United States and Belgium. Li Bian's co-authors include Zefei Jiang, Shaohua Zhang, Xiao‐Jing Wang, Gangwen Han, Yongwen He, Christian D. Young, Yi Liu, Bing Liu, Haixu Hu and Jian Wu and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Li Bian

108 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Bian China 19 484 368 276 227 129 118 1.2k
Alexis Vallard France 18 357 0.7× 324 0.9× 364 1.3× 208 0.9× 193 1.5× 110 1.2k
Jean‐Baptiste Guy France 19 440 0.9× 391 1.1× 458 1.7× 209 0.9× 279 2.2× 90 1.4k
Shoucheng Ning United States 23 327 0.7× 624 1.7× 318 1.2× 241 1.1× 238 1.8× 41 1.5k
Xiao Li China 22 374 0.8× 507 1.4× 171 0.6× 343 1.5× 89 0.7× 142 1.6k
Bea Pauwels Belgium 16 356 0.7× 439 1.2× 209 0.8× 188 0.8× 87 0.7× 30 949
Weiye Deng United States 19 623 1.3× 419 1.1× 381 1.4× 186 0.8× 136 1.1× 43 1.5k
Haruhiko Makino Japan 20 673 1.4× 431 1.2× 345 1.3× 129 0.6× 138 1.1× 83 1.6k
Min Yao China 24 863 1.8× 737 2.0× 285 1.0× 333 1.5× 80 0.6× 68 1.8k
Julio A. Díaz-Pérez United States 20 629 1.3× 344 0.9× 390 1.4× 81 0.4× 70 0.5× 106 1.8k
Eric C. Ko United States 18 530 1.1× 308 0.8× 314 1.1× 109 0.5× 149 1.2× 47 1.2k

Countries citing papers authored by Li Bian

Since Specialization
Citations

This map shows the geographic impact of Li Bian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Bian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Bian more than expected).

Fields of papers citing papers by Li Bian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Bian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Bian. The network helps show where Li Bian may publish in the future.

Co-authorship network of co-authors of Li Bian

This figure shows the co-authorship network connecting the top 25 collaborators of Li Bian. A scholar is included among the top collaborators of Li Bian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Bian. Li Bian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Guoyu, Xiaoyu Zhao, Jiwen Chen, et al.. (2024). DTL promotes head and neck squamous cell carcinoma progression by mediating the degradation of ARGLU1 to regulate the Notch signaling pathway. International Journal of Biological Macromolecules. 259(Pt 2). 129184–129184. 5 indexed citations
4.
Wang, Zhiyuan, Weizhou Wang, Xiaofang Wang, et al.. (2023). Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer. Frontiers in Molecular Biosciences. 10. 1157970–1157970. 8 indexed citations
5.
You, Dingyun, Jianguo Xu, Rongqiang Yang, et al.. (2023). MiR-3529-3p from PDGF-BB-induced cancer-associated fibroblast-derived exosomes promotes the malignancy of oral squamous cell carcinoma. Discover Oncology. 14(1). 166–166. 8 indexed citations
6.
Li, Xing, Yao Ke, Jingjing Yu, et al.. (2023). Inducible nitric oxide synthase (iNOS)-activated Cxcr2 signaling in myeloid cells promotes TGFβ-dependent squamous cell carcinoma lung metastasis. Cancer Letters. 570. 216330–216330. 11 indexed citations
7.
Nguyen, Khoa, Li Bian, Yao Ke, et al.. (2023). Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice. Journal for ImmunoTherapy of Cancer. 11(9). e007110–e007110. 10 indexed citations
8.
Li, Hong, Caiguo Zhang, Li Bian, et al.. (2021). Inhibition of CtBP-Regulated Proinflammatory Gene Transcription Attenuates Psoriatic Skin Inflammation. Journal of Investigative Dermatology. 142(2). 390–401. 4 indexed citations
9.
Nie, Zhi, Shan Cai, Zhimin Wei, et al.. (2021). SH3GL3 acts as a novel tumor suppressor in glioblastoma tumorigenesis by inhibiting STAT3 signaling. Biochemical and Biophysical Research Communications. 544. 73–80. 5 indexed citations
10.
Young, Christian D., Li Bian, Kelsey Weigel, et al.. (2020). PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models. Clinical Cancer Research. 26(12). 3058–3070. 25 indexed citations
11.
Luo, Jingjing, Li Bian, Melanie A. Blevins, et al.. (2018). Smad7 Promotes Healing of Radiotherapy-Induced Oral Mucositis without Compromising Oral Cancer Therapy in a Xenograft Mouse Model. Clinical Cancer Research. 25(2). 808–818. 27 indexed citations
13.
Liu, Yi, Shaohua Zhang, Tao Wang, et al.. (2014). [Detection of circulating tumor cells and its clinical value for different stages and various subtypes of breast cancer].. PubMed. 94(36). 2812–5. 3 indexed citations
14.
Bian, Li, Tao Wang, Shaohua Zhang, et al.. (2014). Ki-67 index as a prognostic factor of subsequent lapatinib-based therapy in HER2-positive metastatic breast cancer with resistance to trastuzumab. Cancer Biology & Therapy. 15(4). 365–370. 3 indexed citations
15.
Huang, Hongyan, Zefei Jiang, Litao Wang, et al.. (2012). Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer. Anti-Cancer Drugs. 23(7). 718–723. 11 indexed citations
16.
Bian, Li. (2011). Study on the malignant transformation of immortalized rat alveolar cells type II RLE-6TN induced by Yunnan tin mine dust. 1 indexed citations
17.
Bian, Li, et al.. (2010). [Expression of fragile histidine triad (FHIT) protein and Ki-67 in transformed epithelial cells induced by Yunnan tin mine dust].. PubMed. 28(12). 895–9. 1 indexed citations
18.
Jiang, Wen, et al.. (2010). Hyperthermia-induced apoptosis in Tca8113 cells is inhibited by heat shock protein 27 through blocking phospholipid scramblase 3 phosphorylation. International Journal of Hyperthermia. 26(6). 523–537. 10 indexed citations
19.
Bian, Li, et al.. (2010). Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction. Medical Oncology. 28(S1). 560–569. 8 indexed citations
20.
Cao, Weidong, Xiang Zhang, Jianning Zhang, et al.. (2005). Immunocytochemical detection of 14-3-3 in primary nervous system tumors. Journal of Neuro-Oncology. 77(2). 125–130. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026